These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8777670)

  • 1. Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.
    Rogers D
    Arch Dis Child Fetal Neonatal Ed; 1996 Mar; 74(2):F151. PubMed ID: 8777670
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse experiences in an Exosurf treated group.
    Chatfield SL; Kelly EJ; Dear PR
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F78. PubMed ID: 8117137
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Speer CP; Robertson B; Halliday HL
    Acta Paediatr; 2000 May; 89(5):510-2. PubMed ID: 10852182
    [No Abstract]   [Full Text] [Related]  

  • 4. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
    Hamdan AH; Shaw NJ
    Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F176-9. PubMed ID: 7796233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute blood pressure response to surfactant administration.
    Halley GC; Stenson BJ; Laing IA; McIntosh M
    Arch Dis Child Fetal Neonatal Ed; 1995 Nov; 73(3):F197. PubMed ID: 8535884
    [No Abstract]   [Full Text] [Related]  

  • 8. Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
    Frey B; Keller E; Losa M
    Eur J Pediatr; 1999 Jul; 158(7):610. PubMed ID: 10412829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cerebral blood flow velocity after surfactant instillation in preterm infants].
    Latini G
    Pediatr Med Chir; 1991; 13(4):439-40. PubMed ID: 1754482
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Hamdan AH; Shaw NJ
    Pediatr Pulmonol; 1998 Mar; 25(3):191-5. PubMed ID: 9556011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary haemorrhage, surfactant, and low-birthweight babies.
    Rogers D
    Lancet; 1993 Mar; 341(8846):698. PubMed ID: 8095608
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Allen A; McMillan D; Boros S; Vaughan R; Gerdes J; Houle L; Edwards K; Schiff D
    J Pediatr; 1992 Feb; 120(2 Pt 2):S45-8. PubMed ID: 1735852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow velocity after surfactant instillation in preterm infants.
    van de Bor M; Ma EJ; Walther FJ
    J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
    Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V
    Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary haemorrhage in low-birthweight babies.
    Majeed-Saidan MA; al-Hifzi I; Khan M
    Lancet; 1993 Jan; 341(8837):120. PubMed ID: 8093391
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of clinical responses to natural and synthetic surfactants.
    Rollins M; Jenkins J; Tubman R; Corkey C; Wilson D
    J Perinat Med; 1993; 21(5):341-7. PubMed ID: 8126629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
    Bassiouny MR; Remo C; Cherian E
    J Trop Pediatr; 1997 Feb; 43(1):38-41. PubMed ID: 9078827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 20. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.